PhRMA General Counsel Kuhlik Joins Oct. 1; Bantham Named COO
Executive Summary
PhRMA is beefing up its intellectual property legal team with the appointments of Bruce Kuhlik as general counsel and Kent Matsumoto as senior director-intellectual property
You may also be interested in...
PhRMA VP Bantham Is Association's Number Two Exec; Bello Leaving
PhRMA General Counsel Russel Bantham is adding the title of exec VP and taking on the role of the number two official in the Pharmaceutical Research & Manufacturers of America trade association.
Pediatric Studies Need Not Apply To Each Product Given Exclusivity - Judge
Pediatric provisions in the FDA Modernization Act do not mandate that pediatric studies have to be "extrapolatable" from specific drug products to other products in the line containing the same active moiety, D.C. Federal Court Judge James Robertson indicated at an April 9 hearing.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011